A dose-finding and pharmacokinetic study of nedaplatin in elderly patients with advanced non-small cell lung cancer

被引:16
|
作者
Yamamoto, Noboru [1 ]
Tamura, Tomohide [1 ]
Kurata, Takayasu [2 ]
Yamamoto, Nobuyuki [3 ]
Sekine, Ikuo [1 ]
Kunitoh, Hideo [1 ]
Ohe, Yuichiro [1 ]
Saijo, Nagahiro [4 ]
机构
[1] Natl Canc Ctr, Div Internal Med, Chuo Ku, Tokyo 1040045, Japan
[2] Osaka Med Coll, Ctr Canc Chemotherapy, Osaka, Japan
[3] Shizuoka Canc Ctr, Div Thorac Oncol, Shizuoka, Japan
[4] Natl Canc Ctr Hosp E, Kashiwa, Chiba, Japan
关键词
Nedaplatin; Dose-finding study; Pharmacokinetics; NSCLC; Elderly patient; III RANDOMIZED-TRIAL; PHASE-III; ANTITUMOR-ACTIVITY; CISPLATIN; CHEMOTHERAPY; PLATINUM; CARBOPLATIN; VINORELBINE; JAPAN;
D O I
10.1007/s00280-009-1006-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nedaplatin is a second-generation platinum showing favorable activity against non-small cell lung cancer (NSCLC). Dose-limiting toxicity (DLT) is thrombocytopenia, predicted by creatinine clearance (Ccr). This study was conducted to determine the recommended dose, and evaluate the toxicities, pharmacokinetics and efficacy for elderly NSCLC patients. Patients a parts per thousand yen70 years were stratified into two groups based on renal functions: Group A, Ccr a parts per thousand yen 60 and Group B, 40 a parts per thousand currency sign Ccr < 60. The initial doses were 80 and 60 mg/m(2) in Groups A and B, respectively. The doses were escalated in 20-mg/m(2) increments to 100 mg/m(2) until DLT. Chemotherapy-na < ve 39 elderly patients (Group A/Group B: 22/17) received a total of 83 cycles. Major toxicities were hematological. In Group A, one of the 15 patients at 100 mg/m(2) experienced DLT (neutropenia) and the recommended dose was determined at 100 mg/m(2). In Group B, three of the five patients had DLTs (leukopenia, neutropenia, thrombocytopenia and febrile neutropenia) at 100 mg/m(2), and the recommended dose was determined at 80 mg/m(2). The percentage decreases of neutrophil were well correlated with total and free-Pt AUCs. Partial responses were observed in 13 (33%) of the 39 patients, and 12 of the 13 patients who responded had a squamous cell carcinoma. Nedaplatin was administered simply and feasibly by stratifying renal function and exerted favorable antitumor activity for elderly patients with NSCLC, especially on squamous cell carcinoma.
引用
收藏
页码:79 / 88
页数:10
相关论文
共 50 条
  • [41] Management of Elderly Patients with Advanced Non-Small Cell Lung Cancer in Turkey
    Yildirim, Yesim
    Ozyilkan, Ozgur
    Calikusu, Zuleyha
    Akcali, Zafer
    Akcay, Yesim
    Demirhan, Beyhan
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2009, 10 (04) : 699 - 700
  • [42] Paclitaxel Carboplatin in Elderly Patients with Advanced Non-Small Cell Lung Cancer
    Kanat, Ozkan
    Cubukcu, Erdem
    Cubukcu, Sinem
    Aksoy, Savas
    Canhoroz, Mustafa
    Karadag, Oya
    Alkis, Nihan
    Manavolglu, Osman
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2012, 3 (03) : 293 - 295
  • [43] Treatment Toxicity in Elderly Patients With Advanced Non-Small Cell Lung Cancer
    Kale, Minal S.
    Mhango, Grace
    Gomez, Jorge E.
    Sigel, Keith
    Smith, Cardinale B.
    Bonomi, Marcelo
    Wisnivesky, Juan P.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2017, 40 (05): : 470 - 476
  • [44] Paclitaxel and Carboplatin in Elderly Patients with Advanced Non-Small Cell Lung Cancer
    Sadic, Murat
    Alavi, Abass
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2016, 7
  • [45] Chemoradiotherapy in Elderly Patients with Locally Advanced Non-Small Cell Lung Cancer
    Linhas, Ana
    Dias, Margarida
    Campainha, Sergio
    Conde, Sara
    Barroso, Ana
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S857 - S858
  • [46] ERLOTINIB FOR CHINESE ELDERLY PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Wang, H-P
    Li, Z.
    Wang, M-Z
    Yi, X.
    RESPIROLOGY, 2011, 16 : 172 - 172
  • [47] Therapeutic options for elderly patients with advanced non-small cell lung cancer
    Avery, Eric J.
    Kessinger, Anne
    Ganti, Apar Kishor
    CANCER TREATMENT REVIEWS, 2009, 35 (04) : 340 - 344
  • [48] Prognostic Factors in Elderly Patients with Advanced Non-Small Cell Lung Cancer
    Honorio, M.
    Guerra Pereira, N.
    Tereso, A.
    Almeida, M. A.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S881 - S881
  • [49] Treatment of advanced non-small cell lung cancer in the elderly
    Sequist, LV
    Fidias, P
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 26 (03) : 289 - 297
  • [50] Treatment of advanced non-small cell lung cancer in the elderly
    Knetki-Wroblewska, Magdalena
    Pluzanski, Adam
    Krzakowski, Maciej
    ONCOLOGY IN CLINICAL PRACTICE, 2011, 7 (01): : 1 - 8